NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag (BUSE: NATURLAND)
Health Care · Pharmaceuticals · HU
Ft2,820.00
-0.70% today · +8.5% 1Y
NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag (BUSE: NATURLAND) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $123.62M.
Over the last twelve months the share price has gained 8.5%, trading between 2.54K and 2.84K.
Tweenvest scores NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag across four factors: quality 75/100, value 24/100. Its strongest factor is quality.
NATURLAND price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $123.62M
- Revenue (TTM)
- $18.80M
- P/E
- 26.62
- EPS
- 105.93
- Dividend yield
- —
- Beta (5Y)
- 0.90
- 52-week high
- Ft2,840.00
- 52-week low
- Ft2,540.00
- Avg volume (3M)
- —
- Shares outstanding
- 13.82M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.